{"pmid":32352025,"pmcid":"PMC7189191","title":"The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic.","text":["The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic.","Int J Womens Dermatol","Stout, Molly","32352025"],"journal":"Int J Womens Dermatol","authors":["Stout, Molly"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352025","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ijwd.2020.04.009","topics":["Prevention"],"weight":1,"_version_":1666138495648792576,"score":9.490897,"similar":[{"pmid":32360857,"title":"Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","text":["Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","J Am Acad Dermatol","Shah, Monica","Naik, Haley B","Alhusayen, Raed","32360857"],"journal":"J Am Acad Dermatol","authors":["Shah, Monica","Naik, Haley B","Alhusayen, Raed"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360857","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.142","keywords":["covid-19","coronavirus","emergency department","hidradenitis suppurativa","operational strategies","outpatient care","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138495570149377,"score":98.25486},{"pmid":32389715,"title":"Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients.","text":["Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients.","J Am Acad Dermatol","Seltzer, Janyla A","Okeke, Chidubem A V","Perry, Jessica D","Shipman, William D","Okoye, Ginette A","Byrd, Angel S","32389715"],"journal":"J Am Acad Dermatol","authors":["Seltzer, Janyla A","Okeke, Chidubem A V","Perry, Jessica D","Shipman, William D","Okoye, Ginette A","Byrd, Angel S"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389715","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jaad.2020.05.012","keywords":["covid-19","sars-cov-2","comorbidities","coronavirus","hidradenitis suppurativa","risk factors"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666528580103831552,"score":81.33961},{"pmid":32283230,"pmcid":"PMC7151529","title":"Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.","text":["Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.","J Am Acad Dermatol","Blaszczak, Alecia","Trinidad, John C L","Cartron, Alexander M","32283230"],"journal":"J Am Acad Dermatol","authors":["Blaszczak, Alecia","Trinidad, John C L","Cartron, Alexander M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283230","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.030","keywords":["covid-19","adalimumab","biologics","coronavirus","hidradenitis suppurativa","immunosuppression"],"e_drugs":["Adalimumab"],"topics":["Treatment"],"weight":1,"_version_":1666138491490140161,"score":77.94306},{"pmid":32447800,"title":"Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.","text":["Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.","Dermatol Ther","Giulia, Rozzo","Alice, Ramondetta","Teresa, Fierro Maria","Paolo, Dapavo","Simone, Ribero","32447800"],"journal":"Dermatol Ther","authors":["Giulia, Rozzo","Alice, Ramondetta","Teresa, Fierro Maria","Paolo, Dapavo","Simone, Ribero"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447800","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13680","keywords":["adalimumab","covid-19","pandemic","apremilast","hidradenitis suppurativa","secukinumab"],"topics":["Treatment"],"weight":1,"_version_":1667698385900011520,"score":75.502686},{"pmid":32432955,"title":"Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment?","text":["Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment?","J Dermatolog Treat","Rosi, Elia","Pimpinelli, Nicola","Prignano, Francesca","32432955"],"journal":"J Dermatolog Treat","authors":["Rosi, Elia","Pimpinelli, Nicola","Prignano, Francesca"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432955","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/09546634.2020.1771256","keywords":["covid-19","adalimumab","biologics","hidradenitis suppurativa","immunosuppression"],"topics":["Prevention"],"weight":1,"_version_":1667342288226877440,"score":73.907585}]}